| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON | EVP, WW Chair, MedTech | Employee Stock Options (Right to Buy) | 49,878 | $4,990,793 | $100.06 | 15 Feb 2025 | Direct |
| JOHNSON & JOHNSON | EVP, WW Chair, MedTech | Common Stock | 15,098 | $2,357,553 | $156.15 | 18 Feb 2025 | Direct |
| JOHNSON & JOHNSON | EVP, WW Chair, MedTech | Restricted Share Units | 3,085 | $486,967 | $157.85 | 15 Feb 2024 | Direct |
| JOHNSON & JOHNSON | EVP, WW Chair, MedTech | Restricted Share Units | 3,077 | $480,474 | $156.15 | 15 Feb 2025 | Direct |
| JOHNSON & JOHNSON | EVP, WW Chair, MedTech | Common Stock | 722 | $112,740 | $156.15 | 14 Feb 2025 | By 401k |
| JOHNSON & JOHNSON | EVP, WW Chair, MedTech | Common Stock | 46 | $7,183 | $156.15 | 14 Feb 2025 | By ESOP |
| JOHNSON & JOHNSON | EVP, WW Chair, MedTech | Performance Share Units | 0 | $0 | $156.15 | 14 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | 15 Feb 2025 | 2 | $0 | 4 | EVP, WW Chair, MedTech | 19 Feb 2025, 17:31 |
| JNJ | JOHNSON & JOHNSON | 14 Feb 2025 | 3 | $-159,061 | 4 | EVP, WW Chair, MedTech | 18 Feb 2025, 21:46 |
| JNJ | JOHNSON & JOHNSON | 13 Feb 2025 | 9 | $-193,031 | 4 | EVP, WW Chair, MedTech | 18 Feb 2025, 21:33 |
| JNJ | JOHNSON & JOHNSON | 10 Feb 2025 | 1 | $0 | 4 | EVP, WW Chair, MedTech | 12 Feb 2025, 18:10 |
| JNJ | JOHNSON & JOHNSON | 15 Feb 2024 | 2 | $0 | 4 | EVP, WW Chair, MedTech | 20 Feb 2024, 17:56 |
| JNJ | JOHNSON & JOHNSON | 13 Feb 2024 | 3 | $-39,462 | 4 | EVP, WW Chair, MedTech | 15 Feb 2024, 16:53 |
| JNJ | JOHNSON & JOHNSON | 12 Feb 2024 | 4 | $-454,414 | 4 | EVP, WW Chair, MedTech | 14 Feb 2024, 18:36 |
| JNJ | JOHNSON & JOHNSON | 08 Feb 2024 | 3 | $-156,486 | 4 | EVP, WW Chair, MedTech | 12 Feb 2024, 19:24 |
| JNJ | JOHNSON & JOHNSON | 23 Oct 2023 | 0 | $0 | 3 | EVP, WW Chair, MedTech | 02 Nov 2023, 16:36 |